Should primary cutaneous Ki-1(CD30)-positive anaplastic large cell lymphoma in childhood be treated with multiple-agent chemotherapy?
Vermeer
M H
MH
Bekkenk
M W
MW
Willemze
R
R
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D018450:Disease Progression; D006801:Humans; D017730:Ki-1 Antigen / Q000032:analysis; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012883:Skin Ulcer / Q000209:etiology / Q000473:pathology
D017730:Ki-1 Antigen